Latest Bimatoprost Stories
Allergan, Inc., the maker of BOTOX ® Cosmetic, ranked The Skin Center Medical Spa in Pittsburgh, PA and Columbus, OH, as one of its top ten medical spas in the U.S. The Skin Center was selected for the coveted designation over thousands of other MedSpas, nationwide. Pittsburgh, PA (PRWEB) May 01, 2013 Allergan, Inc., the maker of BOTOX® Cosmetic, Juvederm® wrinkle treatment and Latisse® eyelash enhancement, has recently announced its 2013 “Top 50” U.S. MedSpas;...
A recent CBS News article highlights Latisse and other drugs, previously developed for alternate uses, have surfaced as potentially effective hair loss treatments. Dr. Simon Ourian of Epione Beverly Hills is excited at the possibilities this offers his patients even if these drugs are a treatment option and not a cure. Los Angeles, California (PRWEB) March 25, 2013 According to a March 17, 2013 CBS News article, the eyelash treatment Latisse is now being explored as a remedy for hair...
On December 19th 2012, Aventura Rejuvenation will be holding their Day of Beauty Event. Discounts will be given out on many of their products and procedures including Botox/Dysport, Radiesse, Restylane/Juvederm, Perlane, Sculptra, and Latisse. Customers that attend will also be provided with free refreshments, weight assessments, raffles, and giveaways. It is also recommended that attendees of this event register at http://www.brilliantdistinctionsprogram.com. Once registered, clients...
BEDFORD, Mass., Oct. 30, 2012 /PRNewswire/ -- Ocular Therapeutix, Inc. announced promising results of their sustained release travoprost (OTX-TP2) study for the treatment of glaucoma and ocular hypertension. OTX-TP2, a drug-eluting intracanalicular plug inserted through the punctum, was evaluated for the reduction of elevated intraocular pressure over a two-month period. The pilot Phase II study enrolled twenty patients (36 eyes) at the Umhlanga Hospital Medical Centre and Netcare...
Lashem is gaining distribution in key retail accounts, including drugstore.com, as a result of competitive eyelash growth products recently being recalled as well as consumer concerns regarding the potential side effects from ingredients in many eyelash serums. Azusa, California (PRWEB) August 20, 2012 Lashem is gaining distribution in key retail accounts, including drugstore.com, as a result of competitive eyelash growth products recently being recalled as well as consumer concerns...
BEDFORD, Mass., July 23, 2012 /PRNewswire/ -- Ocular Therapeutix, Inc. announced today initial results of their sustained release travoprost-loaded punctum plug feasibility study for the treatment of glaucoma. This travoprost punctum plug (OTX-TP1) was evaluated for the reduction of elevated intraocular pressure in subjects with open-angle glaucoma or ocular hypertension over a 30 day period. Twenty six eyes were treated in 17 patients at the Singapore National Eye Center and the...
ISSAQUAH, Wash., July 12, 2012 /PRNewswire/ -- HydroPeptide, the pioneers of the age-defying skin care industry's peptide revolution, is known for its products containing clinical levels of over 21 different peptides and more recently as the winner of over 21 beauty awards. HydroPeptide's portfolio of beauty industry accolades includes a recent addition of five more beauty awards. After weeks of analyzing and tabulating the results of reader's choice surveys, the beauty editors of...
ShapeMed is awarded Black Diamond Status by Allergan, Inc. Only 1% of MDs nationwide receive this designation. Allergan, Inc. is the manufacturer of Botox, Juvederm, and Latisse. Dr. S. Mark McKenna is owner and medical director of ShapeMed - http://www.shapemed.com. Atlanta, GA (PRWEB) June 06, 2012 Shape Medical Wellness Center – ShapeMed (http://www.shapemed.com) - Atlanta, GA, a leading, state-of-the-art laser and aesthetic medicine center has earned Allergan Inc.’s “Black...
PARSIPPANY, N.J., April 3, 2012 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today confirmed that its subsidiary, Watson Laboratories, Inc., filed Abbreviated New Drug Applications (ANDAs) with the U.S. Food and Drug Administration (FDA) seeking approval to market Bimatoprost Ophthalmic Solution, 0.01% and Bimatoprost Ophthalmic Solution, 0.03%. Watson's ANDA products are generic versions of Allergan, Inc.'s LUMIGAN® 0.01% and LATISSE® products, respectively. LUMIGAN®...
Latisse Eyelash Treatment increases length, thickness and darkness of eyelashes. iGrow Laser Hair Rejuvenation System stimulates hair follicles to increase hair growth and treat hair loss and thinning in both men and women. Laguna Niguel, CA (PRWEB) February 22, 2012 Dr. Lorrie Klein, M.D., today announces the launch of her new online store, drskincareproducts.com, that shall be selling Latisse Eyelash Treatment and iGrow Laser Hair Rejuvenation System. The new store shall provide...
